Advanced Insulin Bolus Advisor based on Run-To-Run Control and Case-Based Reasoning
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
This paper presents an advanced insulin bolus advisor for people with diabetes on multiple daily injections or insulin pump therapy. The proposed system, which runs on a smartphone, keeps the simplicity of a standard bolus calculator while enhancing its performance by providing more adaptability and flexibility. This is achieved by means of applying a retrospective optimization of the insulin bolus therapy using a novel combination of run-to-run (R2R) that uses intermittent continuous glucose monitoring data, and case-based reasoning (CBR). The validity of the proposed approach has been proven by in-silico studies using the FDA-accepted UVa-Padova type 1 diabetes simulator. Tests under more realistic in-silico scenarios are achieved by updating the simulator to emulate intrasubject insulin sensitivity variations and uncertainty in the capillarity measurements and carbohydrate intake. The CBR(R2R) algorithm performed well in simulations by significantly reducing the mean blood glucose, increasing the time in euglycemia and completely eliminating hypoglycaemia. Finally, compared to an R2R stand-alone version of the algorithm, the CBR(R2R) algorithm performed better in both adults and adolescent populations, proving the benefit of the utilization of CBR. In particular, the mean blood glucose improved from 166 ± 39 to 150 ± 16 in the adult populations (p = 0.03) and from 167 ± 25 to 162 ± 23 in the adolescent population (p = 0.06). In addition, CBR(R2R) was able to completely eliminate hypoglycaemia, while the R2R alone was not able to do it in the adolescent population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Case-Based Reasoning: Foundational Issues, Methodological Variations, and System Approaches
Aamodt, A., & Plaza, E. (1994) · AI Communications · doi:10.3233/aic-1994-7104 · Cited by 5,624 · cited 2×
“According to Aamodt and Plaza [13], general CBR consists of four steps, as summarized below and, illustrated in Fig.”
MethodIn Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
El-Khatib, F. H., Russell, S. J., Nathan, D. M., Sutherlin, R. G., & Damiano, E. R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000619 · Cited by 403 · cited 1×
“It is important to note that, unlike existing closed-loop control algorithms for glucose control [14]–[16], which deliver an insulin dose every 5 min based on a real-time optimization, our proposed algorithm is a decision support system providing bolus insulin dose recommendations based on retrospective optimization,…”
BackgroundClosed-loop insulin delivery from bench to clinical practice
Hovorka, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.32 · Cited by 342
Validation of home blood glucose meters with respect to clinical and analytical approaches
Brunner, G. A., Ellmerer, M., Sendlhofer, G., Wutte, A., Trajanoski, Z., Schaupp, L., Quehenberger, F., Wach, P., Krejs, G. J., & Pieber, T. R. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.585 · Cited by 119
Robust Fault Detection System for Insulin Pump Therapy Using Continuous Glucose Monitoring
Herrero, P., Calm, R., Vehí, J., Armengol, J., Georgiou, P., Oliver, N., & Tomazou, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600518 · Cited by 52 · cited 2×
“, sensor drifts and communication problems), a fault detection algorithm could be incorporated to the system [31].”
BackgroundMethodSelf-citationIndividual Prognosis of Diabetes Long-term Risks: A CBR Approach
Palaudàries, A., Plaza, E., & Armengol, E. (2001) · Methods of Information in Medicine · doi:10.1055/s-0038-1634463 · Cited by 45 · cited 1×
“The use of CBR for diabetes has been centred on the prognosis and risk of developing diabetes [25].”
Background
Cited by
Machine learning and data mining methods in diabetes research
Kavakiotis, I., Tsave, O., Salifoglou, A., Maglaveras, N., Vlahavas, I., & Chouvarda, I. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.12.005 · Cited by 1,445
“In addition, to improve dosage planning, case-based reasoning was used to optimize the appropriate and effective dose of insulin in T1D [116].”
MethodArtificial intelligence for diabetes management and decision support: Literature review
Contreras, I., & Vehi, J. (2018) · Journal of Medical Internet Research · doi:10.2196/10775 · Cited by 560
“Research groups at the Imperial College London performed an extensive study of an insulin bolus calculator based on case-based reasoning methodology [80-84].”
MethodWearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment
Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2017) · Electronics · doi:10.3390/electronics6030065 · Cited by 237
“[14], ergonomics [15], data/signal processing [16], and software development [17] to mention a few.”
BackgroundTransforming Diabetes Care Through Artificial Intelligence: The Future Is Here
Dankwa-Mullan, I., Rivo, M., Sepulveda, M., Park, Y., Snowdon, J., & Rhee, K. (2019) · Population Health Management · doi:10.1089/pop.2018.0129 · Cited by 217
Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors
Vettoretti, M., Cappon, G., Facchinetti, A., & Sparacino, G. (2020) · Sensors · doi:10.3390/s20143870 · Cited by 176
“[42], the proposed solution in the reuse step was copied from the most similar case retrieved from the CB.”
BackgroundMethodInfluential
Metadata
- Venue
- IEEE Journal of Biomedical and Health Informatics
- Published
- 2014
- Volume
- 19
- Issue
- 3
- Pages
- 1-1
- ISSN
- 2168-2194 (ISSN-L)
- 2168-2208
- OpenAlex
- W1614252265
- Cited by
- 90
- References
- 7
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.